MSB 2.08% 94.0¢ mesoblast limited

Ann: MSB Annual Financial Results and Operational Progress, page-12

  1. 7,057 Posts.
    lightbulb Created with Sketch. 1806
    My summary:

    - We are curing the world of illnesses new and old
    - Have a number of irons in the fire which will be unleashed to the world to heal millions more
    - Extremely safe (based on follow up of patients) and effective based on current use in first world countries and distributed by global pharmaceuticals
    - 92% increase in overall revenue, 127% increase in revenue from partners
    - US$129Mn (A$188Mn) cash in hand to complete FDA review and other trials, deliver existing products to market, continue R&D to build on 1000+ patents

    In short, we are a shareholder (partner) in a company that is healing the world and has potential to easily become the next CSL or even bigger. The question this annual report is asking me is “Have we proven enough for you to bet your house on this as the new millionaire maker?”
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.